Werbung
Werbung

ZYME

ZYME logo

Zymeworks Inc.

23.18
USD
Gesponsert
+0.08
+0.34%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

23.95

+0.77
+3.30%

ZYME Ergebnisberichte

Positives Überraschungsverhältnis

ZYME übertreffen die 23 der letzten 34Schätzungen.

68%

Nächster Bericht

Datum des nächsten Berichts
03. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$14.13M
/
-$0.43
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-48.84%
/
+65.38%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-54.48%
/
+38.71%

Zymeworks Inc. earnings per share and revenue

On 06. Nov. 2025, ZYME reported earnings of -0.26 USD per share (EPS) for Q3 25, beating the estimate of -0.32 USD, resulting in a 20.63% surprise. Revenue reached 27.61 million, compared to an expected 30.05 million, with a -8.10% difference. The market reacted with a -8.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 14.13 million USD, implying an increase of 65.38% EPS, and decrease of -48.84% in Revenue from the last quarter.
FAQ
For Q3 2025, Zymeworks Inc. reported EPS of -$0.26, beating estimates by 20.63%, and revenue of $27.61M, -8.1% below expectations.
The stock price moved down -8.04%, changed from $17.90 before the earnings release to $16.46 the day after.
The next earning report is scheduled for 03. März 2026.
Based on 14 analysts, Zymeworks Inc. is expected to report EPS of -$0.43 and revenue of $14.13M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung